Zymergen

OverviewSuggest Edit

Zymergen is a company that researches, develops and manufactures microbes. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues either inside the body or on the skin to close a wound or to protect against infection. The Company integrates artificial intelligence algorithms and robotic genomic to search the microbial genome, discover new materials, commercialize new products and improve existing bio-manufactured products.

TypePrivate
Founded2013
HQEmeryville, US
Websitezymergen.com
Employee Ratings2.8

Latest Updates

Employees (est.) (Sept 2020)739
Job Openings53
Cybersecurity ratingAMore

Key People/Management at Zymergen

Josh Hoffman

Josh Hoffman

Chief Executive Officer and Co-Founder, Director
Jay Flatley

Jay Flatley

Director
Jed Dean

Jed Dean

VP of Operations and Engineering and Co-Founder
Sandi Peterson

Sandi Peterson

Director
Deep Nishar

Deep Nishar

Director
Judy Gilbert

Judy Gilbert

Chief People Officer
Show more

Zymergen Office Locations

Zymergen has offices in Emeryville, Boise, Medford, Seattle and in 1 other location
Emeryville, US (HQ)
5980 Horton St #105
Boise, US
12426 W Explorer Dr #250
Emeryville, US
5980 Horton St #105
Medford, US
200 Boston Ave #2975
Seattle, US
1624 4th Ave #300
千代田区, JP
4/F East Tower 1-5-1 Otemachi First Square
Show all (6)

Zymergen Financials and Metrics

Summary Metrics

Zymergen's latest funding round in September 2020 was reported to be $300 m. In total, Zymergen has raised $876.1 m
Show all financial metrics

Zymergen Cybersecurity Score

Cybersecurity ratingPremium dataset

A

94/100

SecurityScorecard logo

Human Capital Metrics

Source: github.com
Embed Graph
Show all human capital metrics

Zymergen Online and Social Media Presence

Embed Graph

Zymergen News and Updates

Zymergen raised $300 million because synthetic biology is so hot right now

Zymergen, one of the companies that’s developing biomanufacturing technologies which could reshape any number of industries, said it has raised $300 million in financing yesterday. It’s part of a wave of biotech companies that TechCrunch covered in depth last month. Synthetic biology startups are gi…

Zymergen zielt mit neuer Finanzierung in Höhe von 300 Millionen USD auf die 300-Billionen-Branchen Chemie und Materialien ab

Eine der größten Deep-Tech-Investitionen des Jahres 2020 zur Einführung weiterer Produkte und Entwicklung bahnbrechender Materialien EMERYVILLE, Kalifornien, 9. September 2020 /PRNewswire/ -- Zymergen, das Unternehmen für Wissenschaft und Materialinnovation, hat heute neue Investitionen...

FMC Corporation Collaborates with Zymergen to Accelerate Discovery of Breakthrough Crop Protection Technologies

PHILADELPHIA and EMERYVILLE, Calif., Aug. 20, 2020 /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading agricultural sciences company, and Zymergen, a science and material innovation company focused on rethinking biology, today announced a new collaboration focused on creating...

How California Can Lead The Global Bioeconomy: A Conversation With Zymergen CEO Josh Hoffman

If software is eating the world, biology is going to rebuild it. Zymergen has produced a billion pounds of bio-based products, and they’re just getting started. CEO and co-founder Josh Hoffman talks about the future of the bioeconomy.

Inspired By Nature, Zymergen Brews High-Performance Bio-Electronics

This simple-looking film will probably end up in your next smartphone, laptop, watch, or television. It's made by fermentation—the same process used to make bread and beer. The biomanufacturing era has begun.

As Zymergen Buys EnEvolv, Biological Manufacturing Is Ready To Transform How Industry Makes Everything From Airplanes To Air Jordans

If you could bring to market superior, sustainable materials 20% faster than your competitors, you would have a real market edge. With a boost in technology from just-acquired enEvolv, that's exactly what Zymergen hopes to achieve.
Show more

Zymergen Blogs

How I Learned to Stop Pipetting and Love the Robots

My job as a biologist in the lab used to consist of moving liquids back and forth by hand. At Zymergen, I’m training robots to automate the worst parts of that job, and I’m here to tell you why you should look forward to fully automated luxury science.I’ve been working as a genetic engineer for abou…

The Most Exciting Thing You Can Barely See — Hyaline polyimide film

The Most Exciting Thing You Can Barely Seeby Richard Pieters, President, ProductsThese are challenging times — and certainly unprecedented. Like so many other companies, Zymergen has done whatever we can to help reduce the spread and find a treatment for COVID-19. Everything from volunteering our eq…

Reimagining Electronics with Breakthrough Bio-Fabricated Materials

by Josh Hoffman, CEO and Co-FounderEarlier today we announced the release of HYALINE — a revolutionary new bio-fabricated film that we believe will completely transform the electronics industry. Developed in partnership with Sumitomo Chemical, the Hyaline products have been successfully tested in fl…

Advancing the Pace of New Material Discovery

by Josh Hoffman, CEO, ZymergenEarlier today, we publicly announced our acquisition of enEvolv, the global leader in ultra-high throughput microbial screening and engineering. With this acquisition, we will greatly accelerate our delivery of new, high-value products to market by 20% — and that’s only…

Growing Zymergen’s Opportunity to Drive the Fourth Industrial Revolution through Biology

by Josh Hoffman, CEO, ZymergenThe World Economic Forum and McKinsey recently published a whitepaper in which they recognize Zymergen as a “lighthouse company”, helping drive what they characterize as the Fourth Industrial Revolution (they also presented us with a lighthouse award, which a number of …

Welcome to our new board members

Welcome to Our New Board MembersAt Zymergen, we use biology to create never-before imagined materials. As we continue to scale and build our growing pipeline of next generation products, we’re proud to announce that we’ve appointed Jay Flatley, Chairman of the Board of Illumina, and Sandra E. Peters…
Show more

Zymergen Frequently Asked Questions

  • When was Zymergen founded?

    Zymergen was founded in 2013.

  • Who are Zymergen key executives?

    Zymergen's key executives are Josh Hoffman, Jay Flatley and Jed Dean.

  • How many employees does Zymergen have?

    Zymergen has 739 employees.

  • Who are Zymergen competitors?

    Competitors of Zymergen include allerguard, Ischemia Care and Scailyte.

  • Where is Zymergen headquarters?

    Zymergen headquarters is located at 5980 Horton St #105, Emeryville.

  • Where are Zymergen offices?

    Zymergen has offices in Emeryville, Boise, Medford, Seattle and in 1 other location.

  • How many offices does Zymergen have?

    Zymergen has 6 offices.